News | Proton Therapy | February 10, 2017

Proton therapy seen as more efficacious for various cancers than seven years ago

state of the proton therapy market entering 2017, proton therapy, radiation therapy, Robust Insight survey

February 10, 2017 — Independent market research consultancy Robust Insight recently conveyed a survey commissioned by IBA on the state of the proton therapy market entering 2017. The report is based on an online survey among 1,200 hospitals in order to assess how they view proton therapy today and in the future.

Two hundred twenty-two replies from professionals in radiation oncology were received from 205 institutions in 29 countries. Thirty-six percent of the respondents were from centers performing proton therapy. The main highlights of the study are:

  • Sixty-eight percent of respondents believe that proton therapy will continue to grow rapidly in the future;
  • Eighty-two percent of respondents were aware that proton therapy has lower risk of treatment-induced disorders versus conventional radiation therapy;
  • Compared to a similar study in 2009, proton therapy is seen as more efficacious in 2016 than in 2009 for cancers like pediatric, base-of-skull treatment, lung and prostate;
  • Just over 50 percent of the respondents cite limited clinical evidence and limited reimbursement for proton therapy as the biggest barriers impacting the growth of the field; 
  • Seventy-seven percent of respondents believe there will be more and more clinical evidence demonstrating the benefits of proton therapy; and
  • Seventy-three percent believe that the availability of proton therapy will have a growing impact on centers’ reputation.

For more information: www.robust-insight.co.uk

Related Content

News | Nuclear Imaging

December 3, 2021 — Mirion Technologies, Inc., a global provider of detection, measurement, analysis and monitoring ...

Time December 03, 2021
arrow
News | Coronavirus (COVID-19)

December 2, 2021 — Almost two-thirds of U.S. states failed to prioritize cancer patients for COVID-19 vaccinations ...

Time December 02, 2021
arrow
Videos | Radiation Therapy

Jeffrey T. Chapman, a medical student at the University of Texas Southwestern Medical Center, Explains how watching ...

Time November 24, 2021
arrow
Videos | Radiopharmaceuticals and Tracers

Ana Kiess, M.D., Ph.D., assistant professor of radiation oncology and molecular radiation sciences, Johns Hopkins ...

Time November 17, 2021
arrow
Videos | Radiation Therapy

The Elekta Harmony radiotherapy system gained FDA clearance in the summer of 2021 and was on display for the first time ...

Time November 17, 2021
arrow
News | Radiation Therapy

November 17, 2021 — Radiation can be a powerful cancer therapy, but it doesn’t work for everyone. A new study identifies ...

Time November 17, 2021
arrow
Videos | Radiation Oncology

This is a model of the Toshiba ion beam radiation therapy system at the American Society of Radiation Oncology (ASTRO) ...

Time November 16, 2021
arrow
News | Prostate Cancer

November 16, 2021 — A new Harvey L. Neiman Health Policy Institute study of nearly 800,000 men found that between 2011 ...

Time November 16, 2021
arrow
Videos | Radiation Oncology

Walter Curran, Jr. M.D., FACR, FASCO, GenesisCare global chief medical officer, discusses three technologies that are ...

Time November 16, 2021
arrow
Videos | Radiation Oncology

This is an example of a multileaf collimator (MLC) on the Accuray Thomotherapy radiation therapy system at the American ...

Time November 16, 2021
arrow
Subscribe Now